Biogen Lied In Rosy Growth Forecast, Investor Suit Says
Biogen Inc. misled investors by predicting double-digit revenue growth early this year, only to slash its forecast soon after and send shares plummeting, according to a proposed securities class action filed...To view the full article, register now.
Already a subscriber? Click here to view full article